Archive - January 2019
Takeda to evaluate Crescendo Biologics’ Humabodies
NHS winter figures encouraging ahead of ‘toughest days’
MHRA responds to consultation on Brexit no-deal proposals
NICE recommends Fasenra injection as asthma alternative
Wormwood: How It Could Heal Or Harm Health
Mystery Illness Caused Teen To Lose Eyesight, Smell, Taste
Blood Pressure Drugs Recalled Once Again Over Possible Cancer Risk
FDA Grants Priority Review Designation for Heron Therapeutics’ NDA for HTX-011, a Non-Opioid for Postoperative Pain Management